The Voxel Group

The Voxel Group provides services across three complementary segments:

Diagnostics

Medical imaging, nuclear medicine, radiopharmaceuticals

Therapy

Neurosurgery, diagnostics

IT & infrastructure

IT systems, medical infrastructure, AI, MOBIGEN

Key numbers

21

years in the healthcare sector

40

diagnostic centres

71

diagnostic equipment

1100

doctors and specialists

4

in-house radiopharmaceuticals

3

cyclotrons in Poland

Complementarity and synergy

Wykres kołowy przedstawiający komplementarność i synergię firmy Voxel, zawierający trzy części: IT, Diagnostyka, Terapia.

The structure of the Voxel Group

Diagnostics

97,27%

63,73%

Therapy

100%

IT

100%

50,9%

About the company

We are one of the three
largest networks
of diagnostic imaging centres in Poland

We have our own
IT solutions

We have the capacity
to limit growth

We have a qualified
and experienced
management and medical team

Our sources
of revenue are
diversified

We provide
complementary services

Capitalisation

1 258,2 mln zł

Free-float

62,2%

Revenue 2025

584 mln zł

EBITDA 2025

188,1 mln zł

News

16.10.2026

Take care of your lungs—take advantage of the free lung cancer screening program!

Ladies and Gentlemen, we are pleased to announce that the VOXEL Group has joined a nationwide lung cancer prevention program funded by the National Health Fund (NFZ).

14.07.2026

Short waiting times for PSMA PET-CT and DOTA PET-CT scans in Kraków

The VOXEL Department of Nuclear Medicine announces that short waiting times are available for specialist PET-CT scans using the gallium-68 (Ga-68) tracer.

03.06.2026

Planned changes for cancer patients

The Ministry of Health plans to introduce changes designed to improve access to diagnostic imaging for cancer patients.

30.04.2026

Announcement from VOXEL S.A.

The merger of VOXEL S.A. with its subsidiaries PRO-SCAN sp. z o.o. and SUPRAMED KONIN sp. z o.o.